{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-024633","form_type":"8-K","ticker":"XFOR","cik":"0001501697","company_name":"X4 Pharmaceuticals, Inc","filed_at":"2024-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.701180+00:00","generated_at":"2026-06-01T09:43:27.459846+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"X4 Pharmaceuticals files corporate presentation with no specific material updates provided","bullets":["Filing includes a corporate presentation dated May 22, 2024, but full content not available for analysis.","No new financial or clinical data points are discernible from the limited exhibit excerpt.","The presentation appears to be a routine investor deck; no actionable events reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-024633","json":"https://secwatch.observer/filing/0001628280-24-024633.json","markdown":"https://secwatch.observer/filing/0001628280-24-024633.md","text":"https://secwatch.observer/filing/0001628280-24-024633.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024024633/0001628280-24-024633-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024024633/xfor-20240522.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:43:27.459846+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}